we conclude that the production and specificity of the causative antibodies in this case were controlled by a larger antigenic site , presumably consisting of the drug and/or its metabolites plus rbc antigens , rather than by epitopes of the drug or metabolites alone .
C0003320
antigens
C0003316
epitopes